Acquiring Company
Mentara Therapeutics
Acquired Company
InMed Pharmaceuticals
Melbourne
VancouverBiotechnologyHealth CareTherapeuticsHealthcareDescription
Mentari Therapeutics has completed its merger with InMed Pharmaceuticals. The merger includes a Contingent Value Rights Agreement established to outline potential rights for the parties involved.
Quick answer
Mentara Therapeutics is acquiring InMed Pharmaceuticals, announced November 6, 2026. Mentara Therapeutics is based in Melbourne, Victoria, Australia.
- How much did Mentara Therapeutics pay for InMed Pharmaceuticals?
- The deal value was not disclosed.
- What does Mentara Therapeutics do?
- Mentara Therapeutics is a Melbourne-based developer specializing in treatments for neurodegenerative and neuropsychiatric diseases.
- Where are Mentara Therapeutics and InMed Pharmaceuticals based?
- Mentara Therapeutics is based in Melbourne, Victoria, Australia. InMed Pharmaceuticals is based in Vancouver, British Columbia, Canada.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Healthcare
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Abeona Therapeutics to Acquire APT-1011 Assets from Ellodi Pharmaceuticals (November 9, 2026)
- Acrivon Therapeutics Acquires Aqilion’s Drug Development Programs (November 6, 2026)
- Pelthos to merge with Castle Creek Biosciences (October 30, 2026)
- SpyGlass Pharma, Inc. Acquires Santen Holdings US, Inc. (October 1, 2026)
- BioAdaptives, Inc. to acquire Xycota Biosciences LLC to Expand Biotechnology Portfolio (November 4, 2026)
- Vantive Enters Agreement to Divest Majority of Hemodialysis Assets to Rockwell Medical to Focus on Home Dialysis. (November 4, 2026)
Who to call at Mentara Therapeutics, and when
When Mentara Therapeutics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Mentara Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Mentara Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Mentara Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Mentara Therapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired InMed Pharmaceuticals?
InMed Pharmaceuticals was acquired by Mentara Therapeutics, based in Melbourne. The deal was reported on November 6, 2026. Mentara Therapeutics is a Melbourne-based developer specializing in treatments for neurodegenerative and neuropsychiatric diseases. Mentara Therapeutics is privately held and operates in Biotechnology.
When did Mentara Therapeutics acquire InMed Pharmaceuticals?
Mentara Therapeutics's acquisition of InMed Pharmaceuticals was reported on November 6, 2026. Mentari Therapeutics has completed its merger with InMed Pharmaceuticals. The merger includes a Contingent Value Rights Agreement established to outline potential rights for the parties involved. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does InMed Pharmaceuticals do?
InMed Pharmaceuticals is a global leader in the development, manufacturing and commercialization of rare cannabinoids. It is publicly traded (INM), operating in Healthcare, and is based in Vancouver.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.